Inflation Reduction Act

Inflation Reduction Act proves positive boost for biosimilars
Pharmaphorum
Thu, 10/10/24 - 09:49 am
Inflation Reduction Act
drug pricing
biosimilars
Medicare Issues Updated Rules for Second Round of Drug Negotiations
US News and World Report
Wed, 10/2/24 - 09:49 pm
CMS
drug pricing
Medicare
Inflation Reduction Act
Cancer and diabetes drugs expected to dominate 2025 Medicare negotiations under IRA
BioSpace
Wed, 09/25/24 - 12:08 pm
Inflation Reduction Act
CMS
drug pricing
Pfizer
Merck
Bristol Myers Squibb
cancer
diabetes
Appeals Court Breathes New Life Into PhRMA’s Legal Challenge to IRA
BioSpace
Mon, 09/23/24 - 11:31 am
PhRMA
legal
Inflation Reduction Act
drug pricing
US will still pay at least twice as much after negotiating drug prices
Reuters
Tue, 09/3/24 - 11:21 am
drug pricing
Inflation Reduction Act
Medicare
IRA biosimilar measure intended to boost uptake so far has 'limited' impact: report
Fierce Pharma
Fri, 08/30/24 - 11:25 am
Inflation Reduction Act
Medicare
drug pricing
biosimilars
Pharmas’ IRA court losses mount. They keep pursuing them.
Pharma Voice
Mon, 08/26/24 - 11:01 am
Inflation Reduction Act
Medicare
drug pricing
legal
Will the IRA squash new drugs? Those worries are likely exaggerated, studies say.
Pharma Voice
Thu, 08/22/24 - 11:10 am
innovation
drug development
R&D
Inflation Reduction Act
Pharma’s concerns pile up months after Supreme Court’s landmark Chevron decision
Pharma Voice
Wed, 08/21/24 - 11:18 am
Supreme Court
Chevron Doctrine
FDA
CMS
Inflation Reduction Act
Impact of federal negotiation of prescription drug prices
Brookings
Mon, 08/19/24 - 07:26 pm
Medicare
drug pricing
Inflation Reduction Act
Investors shrug off drug price talks' effects
Axios
Mon, 08/19/24 - 10:09 am
investors
drug pricing
Medicare
Inflation Reduction Act
Medicare drug price cuts could have limited early impact, but grow with time
BioPharma Dive
Fri, 08/16/24 - 11:26 am
Medicare
drug pricing
Inflation Reduction Act
IRA negotiations slash Medicare prices for Big Pharma blockbusters by up to 79%
Fierce Pharma
Thu, 08/15/24 - 11:55 am
Medicare
drug pricing
Inflation Reduction Act
JNJ
Xarelto
Imbruvica
Stelara
Bristol Myers Squibb
Eliquis
Eli Lilly
Jardiance
Merck
Januvia
Amgen
Enbrel
AstraZeneca
Farxiga
Novo Nordisk
Fiasp
Novartis
Entresto
Experts analyze IRA’s effect as the industry awaits negotiated CMS drug prices
BioSpace
Wed, 08/14/24 - 10:44 pm
Medicare
drug pricing
Inflation Reduction Act
CMS
What to watch when Medicare releases first negotiated drug prices
Axios
Wed, 08/14/24 - 11:01 am
Joe Biden
Medicare
drug pricing
Inflation Reduction Act
5 things to know ahead of the Medicare drug price announcement
Beckers Hospital Review
Mon, 08/12/24 - 05:53 pm
Medicare
Inflation Reduction Act
drug pricing
CMS
IRA Reality Check: Four Strategies for Adapting Hub and Copay Programs
Drug Channels
Fri, 08/9/24 - 11:25 am
Inflation Reduction Act
drug pricing
copays
Pharma execs react to final drug price negotiations with Medicare
Pharma Voice
Fri, 08/9/24 - 11:21 am
Medicare
drug pricing
Inflation Reduction Act
Bristol Myers Squibb
Eli Lilly
JNJ
Bayer
Merck
AstraZeneca
Novartis
Amgen
AbbVie
Novo Nordisk
Novo Loses IRA Case as NJ Judge Asserts Price Negotiations Are Voluntary
BioSpace
Thu, 08/1/24 - 11:41 am
Novo Nordisk
legal
drug pricing
Inflation Reduction Act
3 Big Pharma cancer drugs facing inflation penalties
Pharma Voice
Wed, 07/31/24 - 10:27 am
inflation
Inflation Reduction Act
drug pricing
Abecma
Breyanzi
Bristol Myers Squibb
Pfizer
Adcetris
Astellas
Padcev
cancer

Pages